Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Precision Therapeutics Inc (AIPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Precision Therapeutics' Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announces its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY System for automated, direct-to-drain...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics' TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Models

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announces its TumorGenesis subsidiary has identified three thyroid cancer cell types and has isolated the discovery biomarkers....

AIPT : 0.89 (-1.11%)
Precision Therapeutics Has Groundbreaking Approach to Personalized Cancer Treatment, Reports CEOCFO Magazine

Precision Therapeutics is offering ''true personalized oncology,'' CEO Dr. Carl Schwartz tells CEOCFO Magazine, thanks to the company's unique database of tumors, artificial intelligence technology, and...

AIPT : 0.89 (-1.11%)
Precision Therapeutics' Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Center

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced that its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY System for automated, direct-to-drain...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics Reports Third Quarter 2018 Financial Results

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results...

AIPT : 0.89 (-1.11%)
Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer

Helomics will utilize whole genome and outcome data from the U.K. 100,000 Genomes Project to advance its artificial intelligence-based platform for ovarian cancer.

AIPT : 0.89 (-1.11%)
Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that management...

AIPT : 0.89 (-1.11%)
Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has...

AIPT : 0.89 (-1.11%)
Precision Therapeutics' CEO Talks with Uptick Newswire's Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What's on the Horizon

Precision Therapeutics (Nasdaq: AIPT) (The "Company") is a company applying artificial intelligence to personalized medicine and drug discovery. Their CEO, Dr. Carl Schwartz, and Richard Gabriel, a consultant...

AIPT : 0.89 (-1.11%)
Precision Therapeutics Reports First Quarter 2018 Financial Results

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results...

AIPT : 0.89 (-1.11%)
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved...

AIPT : 0.89 (-1.11%)
Technical Perspectives on Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Retractable Technologies, and Tandem Diabetes Care

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on OSUR, AIPT, RVP, and TNDM which can be accessed for free by signing up to www.wallstequities.com/registration....

AIPT : 0.89 (-1.11%)
OSUR : 11.51 (-2.04%)
TNDM : 49.07 (+0.14%)
RVP : 0.75 (+3.45%)
Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has...

AIPT : 0.89 (-1.11%)
Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)
CORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

In a release issued under the same headline earlier today by Precision Therapeautics (NASDAQ:AIPT), please note that the forward-looking statements paragraph was missing. The corrected release follows:...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TV

CEOLive.TV, a news organization that highlights leading CEOs, companies, and industry experts for investors, today released a video interview with Dr. Carl Schwartz, CEO of Precision Therapeutics Inc (NASDAQ:AIPT),...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, today...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics Reports Fiscal Year 2017 Financial Results

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics Announces Record STREAMWAY(R) System Sales in the First Three Months of 2018

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), today provided a sales update from its Skyline Medical division, producer of the FDA-approved STREAMWAY System for automated, direct-to-drain...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced...

AIPT : 0.89 (-1.11%)
SKLN : 1.21 (-11.03%)

Van Meerten Stock Picks

SecureWorks - Pick of the Day
My Stock Pick of the Day belongs to the security software company SecureWorks (SCWX).
SCWX +0.04
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar